CT-814

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCT-814
Drug Alias NameCT-814
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCogentis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCogentis Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsFrontotemporal Dementia

Other Information

ATC CodeN/A
Related LinksN/A